Maximilian Diehn
M.D., Ph.D.
Professor of Radiation Oncology
👥Biography 个人简介
Maximilian Diehn is a pioneer in circulating tumor DNA (ctDNA) technology for cancer detection and monitoring. His laboratory developed highly sensitive methods for detecting minimal residual disease and tracking treatment response through blood-based assays. Diehn's work enables personalized monitoring of cancer patients without invasive biopsies.
Maximilian Diehn是用于癌症检测和监测的循环肿瘤DNA（ctDNA）技术的先驱。他的实验室开发了高度敏感的方法，用于检测微小残留病灶并通过血液检测追踪治疗反应。Diehn的工作使得无需侵入性活检即可对癌症患者进行个性化监测成为可能。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
ctDNA Methods
Developed CAPP-Seq (Cancer Personalized Profiling by deep Sequencing) for ultrasensitive ctDNA detection.
MRD Detection
Advanced minimal residual disease detection for treatment guidance.
Representative Works 代表性著作
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine (2014)
Introduction of CAPP-Seq ctDNA methodology.
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Maximilian Diehn 的研究动态
Follow Maximilian Diehn's research updates
留下邮箱，当我们发布与 Maximilian Diehn（Stanford University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment